June 2017

Agenda

Author: Parkinson's Life editorsPublished: 24 May 2017

Prep: Cook: Serves:

1–30

Jump June, Cambridge and Netheravon, UK

Parkinson’s UK invites campaigners to skydive for the charity throughout June. All participants will receive a welcome pack, a T-shirt and fundraising materials.

The Rock ‘n’ Roll San Diego Marathon, California, US

The Michael J Fox Foundation will be fielding a team at this year’s marathon to raise vital funds for the organisation. Team Fox runners will gain free entry to the race, a branded running singlet and a unique commemorative medal.

Moving Forward, Together conference, Richmond, US

The conference, held at the Sheraton Vancouver Airport Hotel, aims to enrich the connection between those living with Parkinson’s, caregivers and health care professionals. Tickets are priced between $40–60.

4–8

21st International Congress of Parkinson’s Disease & Movement Disorders, Vancouver, British Columbia, Canada

This year’s theme is ‘Pathophysiology of Basal Ganglia Disorders: From Cell to System to Patient’. Listen to speakers at the top of their fields as they discuss topics surrounding movement disorders.

Three Peaks Challenge, UK

Parkinson’s UK invites fundraisers to take part in this iconic challenge, climbing the highest peaks of England, Scotland and Wales over a 24-hour period. The challenge will run every weekend until October.

Tour de Fox, British Columbia, Canada

The Michael J Fox Foundation host their annual cycling event, with all proceeds going towards the foundation. Routes are between 10–75 miles long, all ages are welcome.

Partners in Parkinson’s Grand Rapids, Michigan, US

Head to Partners in Parkinson’s Grand Rapids for a full day of educational seminars and panel discussions. The event includes a resource fair where guests can meet with medical professionals, allied care providers and activity groups.

Bosham Gardens Open Day, Chichester, UK

The picturesque village of Bosham opens its private gardens in aid of The Cure Parkinson’s Trust. Guests will be treated to afternoon tea. Tickets cost £7 per adult and children under 14 go free.

Parkinson’s Education in Detroit Lakes, Minnesota, US

The National Parkinson Foundation will be hosting a free day of talks, the sessions being led by neurologist Dr Tanya Harlow. A complementary meal is included.

Pocono Fox Trot 5k Fun Run, Pennsylvania, US

Come and show your support for the third annual Pocono Fox Trot 5k Fun Run, held in aid of the Michael J Fox Foundation. Last year’s event raised $30,000 and they’re planning to beat that total this year.

24–27

3rd Congress of the European Academy of Neurology, Amsterdam, the Netherlands

Join more than 6000 neurologists from all over the world as they discuss topics on the theme ‘outcome measures in neurology’.

25–1 July

Campus Neurológico Senior Summer Campus 2017, Torres Vedras, Portugal

The week-long event will centre on intensive training, physiotherapy sessions and workshops for both those living with Parkinson’s and caregivers. The workshop also offers an interactive and spirited social programme for guests to enjoy.

Image credit: Campus Neurológico Sénior (CNS)

Last Month

Next Month

Go Back

Share this story

Comments

Perspectives

Michael J Fox is “an inspiration to us all” for laughing at his Parkinson’s symptoms

MJ Fox praised for “laughing” at his Parkinson’s

April 2017

Highlights: World Parkinson’s Day, Symfunny and London Marathon

Which physiotherapy treatment is right for you?

Physiotherapy guidelines reveal best treatments – including Tai Chi

Parkinson’s gene therapy could improve motor symptoms

UK researchers are trialling an innovative gene therapy that could improve motor symptoms – such as tremors and rigidity – experienced by people with Parkinson’s. The therapy, named AXO-Lenti-PD, has been developed by biopharmaceutical companies Oxford BioMedica and Axovant Sciences. The trial will work with 30 participants living with Parkinson’s at hospitals in London and Cambridge, UK and Paris, France. The first stage will evaluate the safety and dosage of the therapy – and the second stage will assess the long-term effects of the therapy on motor function. Professor Thomas Foltynie, neurology consultant at University College London Hospitals – which is carrying out the research alongside University College London – said: “Genes that increase the production of dopamine could help alleviate the symptoms of Parkinson’s disease, potentially with fewer side effects than traditional drug treatments, by targeting only the areas of the brain that are lacking in dopamine.”

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

Pharmaceutical company Pfizer has teamed with investment firm Bain Capital to launch Cerevel Therapeutics – a biopharmaceutical company focused on developing drugs for Parkinson’s and other central nervous system conditions. The new company – which will receive US $350 million of investment from Bain Capital – will begin working on phase three clinical trials on a Parkinson’s drug designed to increase levels of dopamine in the brain. Cerevel will also continue to develop several of Pfizer’s drug programmes which closed earlier this year. Marco Baptista, director of research programmes at The Michael J Fox Foundation – which has partnered with Pfizer since 2010 – said: “This is welcome news for Parkinson’s patients and researchers. Pfizer had developed a diverse group of novel therapeutics for Parkinson’s disease, which are now going to get another chance at success. MJFF looks forward to partnering with Cerevel to support the advancement of these promising…

AI technology could diagnose Parkinson’s in less than three minutes

Chinese technology enterprise Tencent has partnered with UK healthcare company Medopad and the Centre of Excellence in Parkinson’s and Movement Disorders at Kings College Hospital, UK, to create artificial intelligence (AI) software that may be able to diagnose Parkinson’s in less than three minutes. The team trained the AI system by analysing video footage of people with Parkinson’s, and believes it will help doctors identify and diagnose the condition at a far earlier stage. In addition, it is hoped the test could be carried out remotely using smartphone technology. Dan Vahdat, CEO and Co-founder of Medopad, said: “Our partnership with Tencent comes from a shared vision to change the future of healthcare as we know it. “In combining Medopad’s medical expertise and Tencent’s technical capabilities, we hope to provide the technology needed to support clinicians to predict preventable complications for people with Parkinson’s disease.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
Captcha
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

June 2017

Agenda

Author: Parkinson's Life editorsPublished: 24 May 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Perspectives

Michael J Fox is “an inspiration to us all” for laughing at his Parkinson’s symptoms

Agenda

April 2017

PD in Practice

Which physiotherapy treatment is right for you?

Parkinson’s gene therapy could improve motor symptoms

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

AI technology could diagnose Parkinson’s in less than three minutes

{title}

Subscribe

June 2017

Agenda

Author: Parkinson's Life editorsPublished: 24 May 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Perspectives

Michael J Fox is “an inspiration to us all” for laughing at his Parkinson’s symptoms

Agenda

April 2017

PD in Practice

Which physiotherapy treatment is right for you?

Parkinson’s gene therapy could improve motor symptoms

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

AI technology could diagnose Parkinson’s in less than three minutes

{title}

Subscribe

Sign in